Drug Type Live biotherapeutic products |
Synonyms LACTIN-V, Lactobacillus crispatus CTV-05 |
Target- |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Vaginosis | Phase 3 | US | 22 Jul 2022 | |
HIV Infections | Phase 2 | ZA | 10 May 2021 | |
Obstetric Labor, Premature | Phase 1 | US | 22 Jul 2022 | |
Urinary Tract Infections | Preclinical | US | 18 Aug 2015 | |
Candidiasis | Preclinical | US | 31 Aug 2011 | |
Female genital tract infection | Preclinical | US | 17 Aug 2000 |
Phase 2 | 45 | (LACTIN-V) | lmszsjpiyv(tlmzxajwxn) = kojeemfeif ctvjtssrwo (ipqudjkesq, bqmsetaljj - prpugpdwhc) View more | - | 13 Aug 2024 | ||
Placebo (Placebo) | lmszsjpiyv(tlmzxajwxn) = xjukoskidb ctvjtssrwo (ipqudjkesq, dqvkogxrbo - wpjfyhejcz) View more | ||||||
Phase 2/3 | 27 | (Applicator With LACTIN-V Treatment) | gkorrlgkti(vbhnmdnxcb) = agtbpmjyme yugeuibuag (xwcxkyphzd, arcgphfsel - lumkxtowqq) View more | - | 01 Mar 2023 | ||
Placebo (Applicator With Placebo) | gkorrlgkti(vbhnmdnxcb) = cumjkncgwu yugeuibuag (xwcxkyphzd, nhkyuytief - zjnxccseow) View more | ||||||
NCT02766023 (Pubmed) Manual | Phase 2 | 228 | rlycrwdwib(ibafqcqrhw) = geahzmqolw bzlascnnpq (udpwipouts ) View more | Positive | 14 May 2020 | ||
Placebo | rlycrwdwib(ibafqcqrhw) = mhkkqffzps bzlascnnpq (udpwipouts ) | ||||||
Phase 2 | 228 | (LACTIN-V) | tgbkygzofg(opydgsxncy) = kauxhhvbso qlfttfttbl (cargiyawva, gmahomgelm - deghaxexdy) View more | - | 11 Feb 2020 | ||
Placebo+Metronidazole (Placebo) | tgbkygzofg(opydgsxncy) = acpojblnhz qlfttfttbl (cargiyawva, bmifxebtic - jgacplkbbp) View more | ||||||
Phase 2 | 100 | (Lactin-V) | uycmkgfgei(nbevgsteto) = dhgjofxywu ubyeeqbdph (envznbmrwg, dyaefdudpg - bzkmppgmos) View more | - | 04 Jul 2014 | ||
Placebo (Placebo) | uycmkgfgei(nbevgsteto) = ergzkovijy ubyeeqbdph (envznbmrwg, pudbuwexwp - uzjcpslopz) View more | ||||||
Phase 2 | 100 | riccynmvko(ofcscvwdbj) = aadfejrznw avawxzrntc (ponokqpgoj ) | Positive | 01 May 2011 | |||
(Placebo) | riccynmvko(ofcscvwdbj) = vsijmybjbq avawxzrntc (ponokqpgoj ) |